- Home
- SPTN vs PHAR Comparison
SPTN vs PHAR Comparison
Compare SPTN & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPTN
- PHAR
- Stock Information
- Founded
- SPTN 1917
- PHAR 1988
- Country
- SPTN United States
- PHAR Netherlands
- Employees
- SPTN 17000
- PHAR N/A
- Industry
- SPTN Food Distributors
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- SPTN Consumer Discretionary
- PHAR Health Care
- Exchange
- SPTN Nasdaq
- PHAR Nasdaq
- Market Cap
- SPTN 630.9M
- PHAR 618.3M
- IPO Year
- SPTN N/A
- PHAR N/A
- Fundamental
- Price
- SPTN $18.55
- PHAR $8.74
- Analyst Decision
- SPTN Hold
- PHAR Strong Buy
- Analyst Count
- SPTN 1
- PHAR 3
- Target Price
- SPTN $20.00
- PHAR $27.00
- AVG Volume (30 Days)
- SPTN 248.1K
- PHAR 5.6K
- Earning Date
- SPTN 02-12-2025
- PHAR 03-13-2025
- Dividend Yield
- SPTN 4.71%
- PHAR N/A
- EPS Growth
- SPTN 9.92
- PHAR N/A
- EPS
- SPTN 1.33
- PHAR N/A
- Revenue
- SPTN $9,532,883,000.00
- PHAR $285,745,000.00
- Revenue This Year
- SPTN N/A
- PHAR $20.08
- Revenue Next Year
- SPTN $2.15
- PHAR $9.22
- P/E Ratio
- SPTN $14.06
- PHAR N/A
- Revenue Growth
- SPTN N/A
- PHAR 30.64
- 52 Week Low
- SPTN $17.30
- PHAR $6.65
- 52 Week High
- SPTN $23.00
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- SPTN 56.59
- PHAR 40.05
- Support Level
- SPTN $17.77
- PHAR $7.95
- Resistance Level
- SPTN $18.66
- PHAR $9.35
- Average True Range (ATR)
- SPTN 0.40
- PHAR 0.52
- MACD
- SPTN 0.11
- PHAR -0.16
- Stochastic Oscillator
- SPTN 96.19
- PHAR 22.76
About SPTN SpartanNash Company
SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.